Zobrazeno 1 - 10 of 80 pro vyhledávání: '"A C, Negrini"'
1
Akademický článek
Blend of natural and natural identical essential oil compounds as a strategy to improve the gut health of weaning pigs
Autor: D. Luise, F. Correa, C. Negrini, S. Virdis, M. Mazzoni, S. Dalcanale, P. Trevisi
Publikováno v: Animal, Vol 17, Iss 12, Pp 101031- (2023)
Weaning is one of the most critical phases in pig’s life, often leading to postweaning diarrhoea (PWD). Zinc oxide (ZnO), at pharmacological doses, has been largely used to prevent PWD; however, due to antimicrobial co-resistant and environmental p
Externí odkaz: https://doaj.org/article/8a8bb399172f472bb7bd7469fb439402
Zobrazit plný text záznamu
2
Akademický článek
Effect of an Escherichia coli F4/F18 bivalent oral live vaccine on gut health and performance of healthy weaned pigs
Autor: F. Correa, D. Luise, L. Amatucci, F. Palumbo, S. Virdis, C. Negrini, P. Clavenzani, M. Vecchi, M. Mazzoni, P. Bosi, P. Trevisi
Publikováno v: Animal, Vol 16, Iss 11, Pp 100654- (2022)
Oral live vaccines stimulate host immunity, but they could also affect intestinal mucosa development and gut microbiota of piglets during the postweaning. The aim of this study was to determine the effect of an oral vaccine against Escherichia coli F
Externí odkaz: https://doaj.org/article/e11074fdb685401792a51bed88b3aadf
Zobrazit plný text záznamu
4
Akademický článek
Le conseguenze sulla spesa farmaceutica pubblica di un nuovo inibitore di pompa protonica: esomeprazolo
Autor: C. Lucioni, S. Mazzi, C. Negrini
Publikováno v: Farmeconomia: Health Economics and Therapeutic Pathways, Vol 3, Iss 1, Pp 5-14 (2002)
Aim of the present study is to check the economic advantage of esomeprazole, a new proton pump inhibitor that suppresses gastric acid secretion. The efficacy and tolerability of esomeprazole have been already demonstrated, now the pharmacoeconomic st
Externí odkaz: https://doaj.org/article/0ba484a0e5854c5982eae03812bc13ce
Zobrazit plný text záznamu
5
The CAP-CR study: Direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine
Autor: Domenico Amoroso, S. Lopatriello, L. Forti, C. Iacono, A. Smergo, S. Donati, A. Fornasiero, C. Negrini, Oscar Alabiso, A. Lucenti, A. Lalli, L. D’Alonzo
Publikováno v: European Journal of Cancer. 44:2615-2622
Aim To describe the healthcare resource consumption of metastatic colorectal cancer (MCRC) patients in the Italian healthcare setting. Methods A retrospective chart analysis estimating direct medical costs of first-line infusional 5-Fluorouracil (5-F
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d0b079278c306613967e8b579d66b9
https://doi.org/10.1016/j.ejca.2008.08.010
Zobrazit plný text záznamu
7
Impiego di un’associazione fissa di formoterolo e budesonide nel trattamento del paziente asmatico
Autor: Carlo Lucioni, M. Mangrella, S. Mazzi, A. Vaghi, C. Negrini
Publikováno v: PharmacoEconomics Italian Research Articles. 4:15-23
To evaluate the cost-effectiveness of a fixed combination of budesonide and formoterol (B/F) in one inhaler for the treatment of patients with asthma in the framework of some case studies. B/F was compared: 1) with the free association of budesonide
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::653412ce55a58d94ecc52480cf6bad5a
https://doi.org/10.1007/bf03320590
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje